Physician profile
David E Thompson
NPI 1558331033
$6,178.92
in general payments reported to CMS, 2019-2025
24 companies · $81.68 in 2025
The $81.68 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,028 · 2020: $611 · 2021: $703 · 2022: $2,190 · 2023: $463 · 2024: $103 · 2025: $81.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $379 · Travel and Lodging: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.09 |
| Travel and Lodging | $268.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $1,829.63 | 2019-2020 | |
| Medtronic, INC. | $1,616.53 | 2021-2025 | Minimed 780g |
| Novo Nordisk INC | $626.99 | 2019-2025 | Rybelsus, Ozempic |
| Arthrex, INC. | $522.03 | 2022 | |
| Esperion Therapeutics, INC. | $294.47 | 2020-2022 | |
| Smith+Nephew, INC. | $268.87 | 2023 | Spatial Frame |
| Boston Scientific Corporation | $186.64 | 2020-2023 | Watchman Access System, Zoom Wireless Transmitter |
| Abbott Laboratories | $184.52 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.45 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $98.51 | 2020 | |
| Abbvie INC. | $92.68 | 2021 | |
| Lilly USA, LLC | $54.45 | 2020-2021 | |
| Glaxosmithkline, LLC. | $50.98 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $33.50 | 2024 | |
| Lifescan, INC. | $31.83 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $31.05 | 2021 | |
| Corcept Therapeutics | $24.86 | 2023 | Korlym |
| Radius Health, INC. | $18.57 | 2020 | |
| Kyowa Kirin, INC. | $18.06 | 2022 | |
| Atricure, INC. | $17.49 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Tandem Diabetes Care, INC. | $16.16 | 2019 | |
| Ibsa Pharma INC. | $14.68 | 2020 | |
| Amgen INC. | $13.56 | 2025 | Evenity |
| Cequr Corporation | $10.41 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.